Abstract
Biochemical advances are providing new insights into coagulation and fibrinolysis. Integrating this biochemical knowledge into plasminogen activator therapy improves understanding of currently available enzymes. Basic components of the fibrinolytic system are discussed and the chemical structures, pharmacokinetics, dosages, and modes of delivery of current and future plasminogen activators are reviewed.
MeSH terms
-
Antifibrinolytic Agents / metabolism
-
Chemical Phenomena
-
Chemistry
-
Fibrin / metabolism
-
Fibrin / physiology
-
Fibrinolysin / metabolism
-
Fibrinolysin / physiology
-
Fibrinolysis
-
Humans
-
Plasminogen / metabolism
-
Plasminogen / physiology
-
Plasminogen Activators* / metabolism
-
Plasminogen Activators* / pharmacology
-
Plasminogen Activators* / therapeutic use
-
Plasminogen Inactivators / metabolism
Substances
-
Antifibrinolytic Agents
-
Plasminogen Inactivators
-
Fibrin
-
Plasminogen
-
Plasminogen Activators
-
Fibrinolysin